FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286491763> ?p ?o ?g. }

• W4286491763 endingPage "286" @default.
• W4286491763 startingPage "276" @default.
• W4286491763 abstract "Abstract Background and Aims Corticosteroid-free remission is a primary treatment goal in IBD which may be achieved with greater use of anti-TNF therapy. We defined temporal trends of corticosteroid use, anti-TNF use, hospitalization and surgery in a prevalent IBD cohort within the province of Alberta, Canada. Methods Health administrative data were used to identify medication dispensing, hospitalizations and surgery in individuals with IBD from 2010 to 2015. Temporal trends were calculated using log-binomial regression for medications and log-linear models for hospitalizations and surgery rates. Analyses were stratified based on geographic location. Results Of 28890 individuals with IBD, 50.3% had Crohn’s disease. One in six individuals (15.45%) were dispensed a corticosteroid. Corticosteroid use decreased in both metropolitan areas (AAPC −20.08%, 95% CI: −21.78 to −18.04) and non-metropolitan areas (AAPC −18.14%, 95% CI: −20.78 to −18.04) with a similar pattern for corticosteroid dependence. Corticosteroid dependence was more prevalent in UC vs. CD (P &lt; 0.05), and in the pediatric IBD cohort (13.45) compared to the adult (8.89) and elderly (7.54) cohorts (per 100 prevalent population, P &lt; 0.001). The proportion of individuals dispensed an anti-TNF increased over the study period (AAPC 12.58%, 95% CI: 11.56 to 13.61). Significantly more non-metropolitan versus metropolitan residing individuals were hospitalized for any reason, for an IBD-related, or IBD-specific indication (all P &lt; 0.001) though the proportion requiring IBD surgery was similar between groups. Conclusions An increase in anti-TNF use corresponded to a decline in corticosteroid use and dependence in those with IBD. Inequities in IBD care still exist based on location and age." @default.
• W4286491763 created "2022-07-22" @default.
• W4286491763 creator A5008149243 @default.
• W4286491763 creator A5009398098 @default.
• W4286491763 creator A5013202046 @default.
• W4286491763 creator A5027876343 @default.
• W4286491763 creator A5028349320 @default.
• W4286491763 creator A5035437112 @default.
• W4286491763 creator A5037021425 @default.
• W4286491763 creator A5041177228 @default.
• W4286491763 creator A5042526092 @default.
• W4286491763 creator A5043272946 @default.
• W4286491763 creator A5045216057 @default.
• W4286491763 creator A5048572891 @default.
• W4286491763 creator A5062886406 @default.
• W4286491763 creator A5063118598 @default.
• W4286491763 creator A5071998019 @default.
• W4286491763 creator A5074820235 @default.
• W4286491763 creator A5083616352 @default.
• W4286491763 date "2022-07-21" @default.
• W4286491763 modified "2023-10-12" @default.
• W4286491763 title "Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort Study" @default.
• W4286491763 cites W167872630 @default.
• W4286491763 cites W1803773569 @default.
• W4286491763 cites W1895991246 @default.
• W4286491763 cites W1989167852 @default.
• W4286491763 cites W2004608617 @default.
• W4286491763 cites W2020033062 @default.
• W4286491763 cites W2058458670 @default.
• W4286491763 cites W2074223424 @default.
• W4286491763 cites W2080410907 @default.
• W4286491763 cites W2092741754 @default.
• W4286491763 cites W2141997888 @default.
• W4286491763 cites W2143670047 @default.
• W4286491763 cites W2151351996 @default.
• W4286491763 cites W2163278718 @default.
• W4286491763 cites W2182578492 @default.
• W4286491763 cites W2469587942 @default.
• W4286491763 cites W2589546732 @default.
• W4286491763 cites W2614815568 @default.
• W4286491763 cites W2736481586 @default.
• W4286491763 cites W2737806741 @default.
• W4286491763 cites W2760504294 @default.
• W4286491763 cites W2765952171 @default.
• W4286491763 cites W2766046358 @default.
• W4286491763 cites W2782886888 @default.
• W4286491763 cites W2783948361 @default.
• W4286491763 cites W2789644947 @default.
• W4286491763 cites W2888156890 @default.
• W4286491763 cites W2898071195 @default.
• W4286491763 cites W2898624288 @default.
• W4286491763 cites W2898682518 @default.
• W4286491763 cites W2899003764 @default.
• W4286491763 cites W2899378522 @default.
• W4286491763 cites W2900387885 @default.
• W4286491763 cites W2908547111 @default.
• W4286491763 cites W2911482794 @default.
• W4286491763 cites W2949937340 @default.
• W4286491763 cites W2979541008 @default.
• W4286491763 cites W2991706709 @default.
• W4286491763 cites W2998121352 @default.
• W4286491763 cites W3012006062 @default.
• W4286491763 cites W3092547488 @default.
• W4286491763 cites W3115410759 @default.
• W4286491763 cites W3138192661 @default.
• W4286491763 cites W3172209242 @default.
• W4286491763 cites W3212923698 @default.
• W4286491763 cites W4200208566 @default.
• W4286491763 doi "https://doi.org/10.1093/jcag/gwac021" @default.
• W4286491763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36467595" @default.
• W4286491763 hasPublicationYear "2022" @default.
• W4286491763 type Work @default.
• W4286491763 citedByCount "1" @default.
• W4286491763 countsByYear W42864917632023 @default.
• W4286491763 crossrefType "journal-article" @default.
• W4286491763 hasAuthorship W4286491763A5008149243 @default.
• W4286491763 hasAuthorship W4286491763A5009398098 @default.
• W4286491763 hasAuthorship W4286491763A5013202046 @default.
• W4286491763 hasAuthorship W4286491763A5027876343 @default.
• W4286491763 hasAuthorship W4286491763A5028349320 @default.
• W4286491763 hasAuthorship W4286491763A5035437112 @default.
• W4286491763 hasAuthorship W4286491763A5037021425 @default.
• W4286491763 hasAuthorship W4286491763A5041177228 @default.
• W4286491763 hasAuthorship W4286491763A5042526092 @default.
• W4286491763 hasAuthorship W4286491763A5043272946 @default.
• W4286491763 hasAuthorship W4286491763A5045216057 @default.
• W4286491763 hasAuthorship W4286491763A5048572891 @default.
• W4286491763 hasAuthorship W4286491763A5062886406 @default.
• W4286491763 hasAuthorship W4286491763A5063118598 @default.
• W4286491763 hasAuthorship W4286491763A5071998019 @default.
• W4286491763 hasAuthorship W4286491763A5074820235 @default.
• W4286491763 hasAuthorship W4286491763A5083616352 @default.
• W4286491763 hasBestOaLocation W42864917631 @default.
• W4286491763 hasConcept C126322002 @default.
• W4286491763 hasConcept C144024400 @default.
• W4286491763 hasConcept C149923435 @default.
• W4286491763 hasConcept C201903717 @default.
• W4286491763 hasConcept C2776804153 @default.

• next